E. Sathyajith Kumarasinghe

Statistics

Publications

Citations

1.4K

H-Index

Active since

2000

Affiliations

Moderna Therapeutics (United States)(Current)

Bayer (Germany)

Bayer (United States)

E. Sathyajith Kumarasinghe is an author at Moderna Therapeutics (United States) specializing in pharmacology, messenger rna delivery, and molecular pharmacology.

Publications per year

2000–2019

Publications

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Staci Sabnis, E. Sathyajith Kumarasinghe, Timothy Salerno et al. · Molecular Therapy · 2018 · 794 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +16

Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia

An Ding, Jessica L. Schneller, Andrea Frassetto et al. · Cell Reports · 2017 · 260 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +16

Systemic messenger RNA as an etiological treatment for acute intermittent porphyria

Lei Jiang, Pedro Berraondo, Daniel Jericó et al. · Nature Medicine · 2018 · 180 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +8

mRNA Therapy Improves Metabolic and Behavioral Abnormalities in a Murine Model of Citrin Deficiency

Jingsong Cao, An Ding, Mikel Galduroz et al. · Molecular Therapy · 2019 · 72 citations · Full text

Medicine, Molecular Medicine, Pharmacology +15

PDE-10A inhibitors as insulin secretagogues

Louis‐David Cantin, Steven Magnuson, David Gunn et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 35 citations · Full text

Medicine, Endocrinology, Pharmacology +11

1–5 of 9